The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist

International Journal for Parasitology

Volumn 37, Issue 10, 2007, Pages 1087-1096

  Kima, Peter E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Amastigote; Dendritic cells; IL 12; Leishmania; Macrophages; Nitric oxide; Protozoan; Superoxide

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA;

DISEASE VECTOR; FLY; HOST-PARASITE INTERACTION; IMMUNE RESPONSE; INFECTIOUS DISEASE; INFECTIVITY; LESION; NITRIC OXIDE; PARASITE; PROTEIN; PROTOZOAN;

AMASTIGOTE; CELL NUCLEUS; CELL VACUOLE; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INTERNALIZATION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PERSISTENT INFECTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; LEISHMANIA; LEISHMANIASIS; SIGNAL TRANSDUCTION;

HARNESS; MAMMALIA; PROTOZOA;

EID: 34447259748     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.04.007     Document Type: Review

References (88)

1. phox. J. Immunol. 164 (2000) 3946-3949
2. Basu M.K., and Ray M. Macrophage and Leishmania: an unacceptable coexistence. Crit. Rev. Microbiol. 31 (2005) 145-154
3. Belkaid Y., Butcher B., and Sacks D.L. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28 (1998) 1389-1400
4. Bennett C.L., Misslitz A., Colledge L., Aebischer T., and Blackburn C.C. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol. 31 (2001) 876-883
5. Blanchette J., Racette N., Faure R., and Siminovitch K.A. Olivier M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur. J. Immunol. 29 (1999) 3737-3744
6. Blanchette J., Jaramillo M., and Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 108 (2003) 513-522
7. Bogdan C., Donhauser N., Doring R., Rollinghoff M., Diefenbach A., and Rittig M.G. Fibroblasts as host cells in latent leishmaniosis. J. Exp. Med. 191 (2000) 2121-2130
8. Bogdan C., Rollinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 173 (2000) 17-26
9. Brandonisio O., Spinelli R., and Pepe M. Dendritic cells in Leishmania infection. Microbes. Infect. 6 (2004) 1402-1409
10. Cameron P., McGachy A., Anderson M., Paul A., Coombs G.H., Mottram J.C., Alexander J., and Plevin R. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-κB signaling pathway. J. Immunol. 173 (2004) 3297-3304
11. Caron E., and Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282 (1998) 1717-1721
12. Carrera L., Gazzinelli R.T., Badolato R., Hieny S., Muller W., Kuhn R., and Sacks D.L. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183 (1996) 515-526
13. Channon J.Y., Roberts M.B., and Blackwell J.M. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology 53 (1984) 345-355
14. Colmenares M., Puig-Kröger A., Pello O.M., Corbi A.L., and Rivas L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277 (2002) 36766-36769
15. Colmenares M., Corbi A.L., Turco S.J., and Rivas L. The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania. J. Immunol. 172 (2004) 1186-1190
16. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., and Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178 (1993) 1041-1048
17. de Freitas Balanco J.M., Moreira M.E., Bonomo A., Bozza P.T., Amarante-Mendes G., Pirmez C., and Barcinski M.A. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol. 11 (2001) 1870-1873
18. DeLeo F.R., Burritt J.B., Yu L., Jesaitis A.J., Dinauer M.C., and Nauseef W.M. Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J. Biol. Chem. 275 (2000) 13986-13993
19. Descoteaux A., and Turco S.J. Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection. Microbes. Infect. 4 (2002) 975-981
20. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A.B., and Henson P.M. A new receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
21. Feng G.J., Goodridge H.S., Harnett M.M., Wei X.Q., Nikolaev A.V., Higson A.P., and Liew F.Y. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163 (1999) 6403-6412
22. phox and on NADPH oxidase activation. Biochemistry 41 (2002) 7743-7750
23. Forget G., Siminovitch K.A., Brochu S., Rivest S., Radzioch D., and Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31 (2001) 3185-3196
24. Forget G., Gregory D.J., and Olivier M. Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani. J. Biol. Chem. 280 (2005) 30542-30549
25. Gallois A., Klein J.R., Allen L.A., Jones B.D., and Nauseef W.M. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166 (2001) 5741-5748
26. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., and Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167 (2001) 893-901
27. Ghosh S., May M.J., and Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
28. Gregory D.J., and Olivier M. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 130 Suppl (2005) S27-S35
29. Guizani-Tabbane L., Ben-Aissa K., Belghith M., Sassi A., and Dellagi K. Leishmania major amastigotes induce p50/c-Rel NF-κB transcription factor in human macrophages: involvement in cytokine synthesis. Infect. Immun. 72 (2004) 2582-2589
30. Guy R.A., and Belosevic M. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect. Immun 61 (1993) 1553-1558
31. Hall A.B., Gakidis M.A., Glogauer M., Wilsbacher J.L., Gao S., Swat W., and Brugge J.S. Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis. Immunity 24 (2006) 305-316
32. Ilgoutz S.C., and McConville M.J. Function and assembly of the Leishmania surface coat. Int. J. Parasitol. 31 (2001) 899-908
33. Kane M.M., and Mosser D.M. role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166 (2001) 1141-1147
34. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., and McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191 (2000) 1063-1068
35. Laskay T., van Zandbergen G., and Solbach W. Neutrophil granulocytes-Trojan horses for Leishmania major and other intracellular microbes?. Trends Microbiol. 11 (2003) 210-214
36. Lodge R., and Descoteaux A. Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur. J. Immunol. 36 (2006) 2735-2744
37. Love D.C., Mentink Kane M., and Mosser D.M. Leishmania amazonensis: the phagocytosis of amastigotes by macrophages. Exp. Parasitol. 88 (1998) 161-171
38. Ma X., and Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79 (2001) 55-92
39. Marth T., and Kelsall B.L. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185 (1997) 1987-1995
40. Martin M., Schifferle R.E., Cuesta N., Vogel S.N., Katz J., and Michalek S.M. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171 (2003) 717-725
41. Martiny A., Vannier-Santos M.A., Borges V.M., Meyer-Fernandes J.R., Assreuy J., Cunha e Silva N.L., and de Souza W. Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection. Eur. J. Cell. Biol. 71 (1996) 206-215
42. Martiny A., Meyer-Fernandes J.R., de Souza W., and Vannier-Santos M.A. Altered tyrosine phosphorylation of ERK1 MAP kinase and other macrophage molecules caused by Leishmania amastigotes. Mol. Biochem. Parasitol. 1021 (1999) 1-12
43. May M.J., and Ghosh S. Rel/NF-κB and IκB proteins: an overview Semin. Cancer Biol. 8 (1997) 63-73
44. McConville M.J., and Blackwell J.M. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266 (1991) 15170-15179
45. McDowell M.A., and Sacks D.L. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr. Opin. Microbiol. 2 (1999) 438-443
46. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
47. Medema R.H., Kops G.J., Bos J.L., and Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by ras and PKB through p27kip1. Nature 404 (2000) 782-787
48. Melby P.C., Chandrasekar B., Zhao W., and Coe J.E. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 166 (2001) 1912-1920
49. Miles S.A., Conrad S.M., Alves R.G., Jeronimo S.M., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201 (2005) 747-754
50. Moll H., Fuchs H., Blank C., and Rollinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23 (1993) 1595-1601
51. Morehead J., Coppens I., and Andrews N.W. Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis. Infect. Immun. 70 (2002) 4571-4580
52. Mottram J.C., Coombs G.H., and Alexander J. Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 7 (2004) 375-381
53. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., and Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 1995 10 (1995) 5258-5267
54. Murray H.W., and Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189 (1999) 741-746
55. Naderer T., Vince J.E., and McConville M.J. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr. Mol. Med. 4 (2004) 649-665
56. Nandan D., and Reiner N.E. Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 63 (1995) 4495-4500
57. Nandan D., and Reiner N.E. Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin. Immunol. 114 (2005) 266-277
58. Nauseef W.M. Assembly of the phagocyte NADPH oxidase. Histochem. Cell. Biol. 122 (2004) 277-291
59. Olivier M., Gregory D.J., and Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18 (2005) 293-305
60. Otterbein L.E., and Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung. Cell. Mol. Physiol. 279 (2000) L1029-L1037
61. Pearson R.D., Harcus J.L., Roberts D., and Donowitz G.R. Differential survival of Leishmania donovani amastigotes in human monocytes. J. Immunol. 131 (1983) 1994-1999
62. Pelkmans L., Kartenbeck J., and Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell. Biol. 3 (2001) 473-483
63. Perez L.E., Chandrasekar B., Saldarriaga O.A., Zhao W., Arteaga L.T., Travi B.L., and Melby P.C. Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen. J. Immunol. 176 (2006) 5519-5528
64. Peters C., Aebischer T., Stierhof Y.D., Fuchs M., and Overath P. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J. Cell. Sci. 108 (1995) 3715-3724
65. Pham N.K., Mouriz J., and Kima P.E. Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infect. Immun. 73 (2005) 8322-8333
66. Prina E., Abdi S.Z., Lebastard M., Perret E., Winter N., and Antoine J.C. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J. Cell. Sci. 117 (2004) 315-325
67. Prive C., and Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol. 30 (2000) 2235-2244
68. Ray M., Gam A.A., Boykins R.A., and Kenney R.T. Inhibition of interferon-gamma signaling by Leishmania donovani. J. Infect. Dis. 181 (2000) 1121-1128
69. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13 (1995) 151-177
70. Rodriguez N.E., Gaur U., and Wilson M.E. Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell. Microbiol. 8 (2006) 1106-1120
71. Rodriguez-Sosa M., Monteforte G.M., and Satoskar A.R. to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol. Cell. Biol. 79 (2001) 320-322
72. Ruhland A., Leal N., and Kima P.E. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell. Microbiol. 9 (2007) 84-96
73. Scott P. Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol. Res. 27 (2003) 489-498
74. Scott P., and Trinchieri G. IL-12 as an adjuvant for cell-mediated immunity. Semin Immunol. 9 (1997) 285-291
75. Shapira S., Harb O.S., Margarit J., Matrajt M., Han J., Hoffmann A., Freedman B., May M.J., Roos D.S., and Hunter C.A. Initiation and termination of NF-κB signaling by the intracellular protozoan parasite Toxoplasma gondii. J. Cell. Sci. 118 Pt 15 (2005) 3501-3508
76. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
77. Taillé C., El-Benna S.J., Lanone M.C., Dang E., Ogier-Denis M., Aubier M., and Boczkowski J. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J. Biol. Chem. 279 (2004) 28681-28688
78. Turco S.J. Adversarial relationship between the Leishmania lipophosphoglycan and protein kinase C of host macrophages. Parasite Immunol. 21 (1999) 597-600
79. Underhill D.M., and Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20 (2002) 825-852
80. Waggoner S.N., Cruise M.W., Kassel R., and Hahn Y.S. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175 (2005) 4706-4714
81. Wanderley J.L., Moreira M.E., Benjamin A., Bonomo A.C., and Barcinski M.A. Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L.) amazonensis in mammalian hosts. J. Immunol. 176 (2006) 1834-1839
82. Weinheber N., Wolfram M., Harbecke D., and Aebischer T. Phagocytosis of Leishmania mexicana amastigotes by macrophage leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28 (1998) 2467-2477
83. Yang Z., Mosser D.M., and Zhang X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol. 178 (2007) 1077-1085
84. Yu L., DeLeo F.R., Biberstine-Kinkade K.J., Renee J., Nauseef W.M., and Dinauer M.C. Biosynthesis of flavocytochrome b558. gp91(phox) is synthesized as a 65-kDa precursor (p65) in the endoplasmic reticulum. J. Biol. Chem. 274 (1999) 4364-4369
85. Zhang W.W., and Matlashewski G. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol. Microbiol. 39 (2001) 935-948
86. Zhang W.W., Mendez S., Ghosh A., Myler P., Ivens A., Clos J., Sacks D.L., and Matlashewski G. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J. Biol. Chem. 278 (2003) 35508-35515
87. Zhang K., Hsu F.F., Scott D.A., Docampo R., Turk J., and Beverley S.M. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol. Microbiol. 55 (2005) 1566-1578
88. Zufferey R., Allen S., Barron T., Sullivan D.R., Denny P.W., Almeida I.C., Smith D.F., Turco S.J., Ferguson M.A., and Beverley S.M. Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J. Biol. Chem. 278 (2003) 44708-44718